Table 3.
Both mRNA vaccines (n=340522) | BNT162b2 vaccine (n=164669) | mRNA-1273 vaccine (n=175816) | |
---|---|---|---|
Non-serious | 313499 (92.1%) | 150486 (91.4%) | 162977 (92.7%) |
Serious, including death | 27023 (7.9%) | 14183 (8.6%) | 12839 (7.3%) |
Serious, excluding death | 22527 (6.6%) | 12078 (7.3%) | 10448 (5.9%) |
Death | 4496 (1.3%) | 2105 (1.3%) | 2391 (1.4%) |